¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀ忬±¸ÇÐȸ (¿Â¶óÀÎ) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀ忬±¸ÇÐȸ (¿Â¶óÀÎ) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-16
±³À°ÀÏÀÚ : 2020-12-16
±³À°Àå¼Ò : ±×·£µå¿öÅ©Èú  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis      
ÁÖÃÖ±â°ü : ´ëÇÑÀ忬±¸ÇÐȸ
´ã´çÀÚ : ±èº¸¶÷
¿¬¶ôó : 02-957-6145  
À̸ÞÀÏ : thekasid2@gmail.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í AOCC Member US$ 30/ Non-Member US$ 40/Trainee , Resident, Nurse, Pharmacist, Researcher, Exhibitor US$ 20      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 09:30~10:00 Targeting success – A tight disease control strategy in IBD  Edward V. Loftus Jr.(Mayo Clinic) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:00~10:30 Targeting success – A tight disease control strategy in IBD  Taku Kobayashi(Kitasato University Kitasato Institute Hospital) 
È޽Ġ12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:30~10:50 È޽Ġ ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:50~11:10 Epidemiological trends of IBD: What is new?  Siew Chien Ng(The Chinese University of Hong Kong) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:10~11:30 Diagnostic challenges of IBD: How to differentiate IBD mimics?  Zhihua Ran(Shanghai Jiao-Tong University School of Medicine) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:30~11:50 Smart use of thiopurine and anti-TNF: What should we know?  Tadakazu Hisamatsu(Kyorin University) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:50~12:05 ±¸¿¬¹ßÇ¥  Abstract(Abstract) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:05~12:20 ±¸¿¬¹ßÇ¥  Abstract(Abstract) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:20~12:50 Why sequencing matters?  Katsuyoshi Matsuoka(Toho University Sakura Medical Center) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:50~13:20 Which therapy and when?  Brian L Bressler(University of British Columbia) 
È޽Ġ12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 13:20~13:40 È޽Ġ ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 13:40~14:00 Good bugs and bad bugs in colitis and colitis-associated cancer  Christian Jobin(University of Florida) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:00~14:20 Viruses and fungi in the pathogenic and therapeutic perspectives  Takayuki Imai(Shiga University of Medical Science) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:20~14:40 FMT: Where are we now and where are we going?  Young-Seok Cho(The Catholic University of Korea) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:40~15:00 The future of microbiome engineering for IBD treatment  Harry Sokol(Saint-Antoine Hospital) 
Åä·Ð 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:00~15:10 Discussion  ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ) 
È޽Ġ12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:10~15:20 È޽Ġ ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:30~15:45 Part 1. Small bowel CDIdentification of stricture characteristic using cross sectional images: inflammatory vs fibrotic  Se Hyung Kim(Seoul National University) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:45~16:00 Part 1. Small bowel CDNonsurgical therapies: drugs and balloon  Takayuki Matsumoto(Iwate Medical University) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:00~16:15 Part 1. Small bowel CDSurgical treatment: optimal timing, preparation, and technique  Willem A. Bemelman(Amsterdam University Medical Centers) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:15~16:30 Part 2. Acute severe UCOptimal strategies for drug therapy: Which one, when, and how?  Hiroshi Nakase(Sapporo Medical University) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:30~16:45 Part 2. Acute severe UCReview of outcome predictors: prognosticators and available indices  Silvio Danese(Humanitas Research Hospital) 
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:45~17:00 Part 2. Acute severe UCState of the art for surgical treatment  Kyu Joo Park(Seoul National University) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀ忬±¸ÇÐȸ (¿Â¶óÀÎ) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2020 ´ëÇÑÀç³­ÀÇÇÐȸ Çмú´ëȸ : 2020-12-17
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 12¿ù ¿¬¼ö°­Á : 2020-12-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 46 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷